Evaluating and improving orphan drug regulations in Europe: A Delphi policy study
-
Drug Patents: A New Hedge Fund Target – Courtesy ( Seeking Alpha.com)
Pharma Live, , Intellectual Property Rights, 0
Summary Hedge funds managers are attacking what they see as “weak patents” held by pharmaceutical companies while they are...
-
Drug patents are Bad for your health: the cost of mismarketing – By Dean Baker
Pharma Live, , Intellectual Property Rights, 0
The rationale for granting patents for new drugs is to give companies incentives to research new and better drugs....
-
Judge Finds Biosimilar Patent Procedures Optional – Courtesy (Pharma Patent)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 MARCH 2015POSTED IN BIOSIMILARSJudge Seeborg of the U.S. District Court for the Northern District of...
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
-
GW Pharmaceuticals Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy – Courtesy( Biospace)
Pharma Live, , Intellectual Property Rights, 0
GW Pharmaceuticals plc (AIM:GWP) (Nasdaq:GWPH) (“GW”) announced that the United States Patent and Trademark Office (USPTO) has issued a...
-
Orexigen and Takeda Feud Over Cost of a Controversial Diet Drug Trial – Courtesy (Pharmalot)
Pharma Live, , Intellectual Property Rights, 0
The controversy surrounding Orexigen Therapeutics OREX -0.20% and its release of interim study data for its Contrave diet pill...
-
Wyeth denied patent for cancer drug – Courtesy ( The Financial Express)
Pharma Live, , Intellectual Property Rights, 0
Wyeth, which was acquired by US- based pharma major Pfizer Inc, has suffered a major setback in India with...
-
FDA Releases Draft Guidance on Biosimilars
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...